Imre Pavo

Imre Pavo

UNVERIFIED PROFILE

Are you Imre Pavo?   Register this Author

Register author
Imre Pavo

Imre Pavo

Publications by authors named "Imre Pavo"

Are you Imre Pavo?   Register this Author

52Publications

1168Reads

12Profile Views

Insulin exposure mitigates the increase of arterial stiffness in patients with type 2 diabetes and albuminuria: an exploratory analysis.

Acta Diabetol 2019 May 22. Epub 2019 May 22.

Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki (C318b), Haartmaninkatu 8, 00290, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00592-019-01351-4DOI Listing
May 2019

Regenerative therapies in young hearts with structural or congenital heart disease.

Transl Pediatr 2019 Apr;8(2):140-150

Pediatric Heart Center, Justus-Liebig University, Giessen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tp.2019.03.01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514281PMC
April 2019

Clinical cardiac regenerative studies in children.

World J Cardiol 2017 Feb;9(2):147-153

Imre J Pavo, Ina Michel-Behnke, Division of Pediatric Cardiology, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4330/wjc.v9.i2.147DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329741PMC
February 2017

Teriparatide in patients with osteoporosis and type 2 diabetes.

Bone 2016 10 1;91:152-8. Epub 2016 Jul 1.

Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bone.2016.06.017DOI Listing
October 2016

Heme oxygenase contributes to estradiol and raloxifene-induced vasorelaxation in estrogen deficiency.

Int J Cardiol 2015 16;189:252-4. Epub 2015 Apr 16.

Department of Physiology, Anatomy and Neuroscience, Faculty of Science and Informatics, University of Szeged, Kozep fasor 52, H-6726 Szeged, Hungary.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01675273150083
Publisher Site
http://dx.doi.org/10.1016/j.ijcard.2015.04.112DOI Listing
April 2016

Endogenous Estrogen-Mediated Heme Oxygenase Regulation in Experimental Menopause.

Oxid Med Cell Longev 2015 6;2015:429713. Epub 2015 May 6.

Department of Physiology, Anatomy and Neuroscience, Faculty of Science and Informatics, University of Szeged, Kozep Fasor 52, Szeged 6726, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/429713DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438186PMC
April 2016

Influence of Postprandial Hyperglycemic Conditions on Arterial Stiffness in Patients With Type 2 Diabetes.

J Clin Endocrinol Metab 2016 Mar 5;101(3):1134-43. Epub 2016 Jan 5.

Folkhälsan Institute of Genetics (D.G., M.S., J.T., A.S.-P., C.F., K.P., P.-H.G.), Folkhälsan Research Center, Biomedicum Helsinki, FI-00014 Helsinki, Finland; Abdominal Center Nephrology FI-00290 (D.G., M.S., J.T., A.S.-P., C.F., P.-H.G.), University of Helsinki and Helsinki University Hospital, and Research Program Unit (D.G., M.S., J.T., A.S.-P., C.F., P.-H.G.), Department of Diabetes and Obesity, University of Helsinki FI-00014, and Division of Cardiology (K.P.), Department of Medicine, Helsinki University Central Hospital, FI-00290 Helsinki, Finland; Eli Lilly Export SA (B.S.-H.), Vernier, 1214 Geneva, Switzerland; ClinBAY (F.V., L.N.), 1470 Genappe, Belgium; Eli Lilly (I.P.), A-1030 Vienna, Austria; Eli Lilly (V.K.), 00330 Helsinki, Finland; and Baker IDI and Diabetes Institute (P.-H.G.), Melbourne, 3004 Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2015-3635DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803174PMC
March 2016

Sexual dimorphism of cardiovascular ischemia susceptibility is mediated by heme oxygenase.

Oxid Med Cell Longev 2013 17;2013:521563. Epub 2013 Sep 17.

Department of Physiology, Anatomy and Neuroscience, Faculty of Science and Informatics, University of Szeged, Közép Fasor 52, Szeged H 6726, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2013/521563DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791627PMC
May 2014

Postmenopausal women with osteoporosis: experience when treated with teriparatide in clinical practice.

Curr Med Res Opin 2011 Feb 20;27(2):343-53. Epub 2010 Dec 20.

Bone and Mineral Metabolism Unit, Rambam Health Care Campus, Technion Faculty of Medicine, Haifa, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007995.2010.540007DOI Listing
February 2011

Teriparatide reduces bone microdamage accumulation in postmenopausal women previously treated with alendronate.

J Bone Miner Res 2009 Dec;24(12):1998-2006

Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Medical University of Graz, Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1359/jbmr.090527DOI Listing
December 2009

Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis.

J Bone Miner Res 2007 Aug;22(8):1173-80

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1359/jbmr.070413DOI Listing
August 2007

The effect of raloxifene after discontinuation of long-term alendronate treatment of postmenopausal osteoporosis.

J Clin Endocrinol Metab 2006 Mar 13;91(3):870-7. Epub 2005 Dec 13.

Third Department of Internal Medicine, Charles University, Faculty of Medicine, U Nemocnice 1, 128 00 Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2004-2212DOI Listing
March 2006

Comparing raloxifene with continuous combined estrogen-progestin therapy in postmenopausal women: Review of Euralox 1.

Maturitas 2005 Oct;52(2):87-101

Department of Gynaecological Oncology and Multidisciplinary Breast Centre, UZ-Gasthuisberg, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.maturitas.2005.03.010DOI Listing
October 2005

Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy.

J Clin Endocrinol Metab 2005 Jul 19;90(7):3970-7. Epub 2005 Apr 19.

Department of Internal Medicine, Division of Endocrinology, Medical University, Auenbruggerplatz 15, A-8036 Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2003-1703DOI Listing
July 2005

Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels.

J Bone Miner Res 2004 Sep 3;19(9):1518-24. Epub 2004 May 3.

Service of Bone Diseases (WHO Collaborating Center for Osteoporosis Prevention), Department of Rehabilitation and Geriatrics, University Hospital, Geneva 14 CH-1211, Switzerland.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1359/JBMR.040503
Publisher Site
http://dx.doi.org/10.1359/JBMR.040503DOI Listing
September 2004

Synergistic interaction of endogenous platelet-activating factor and vasopressin in generating angina in rats.

Eur J Pharmacol 2004 Sep;498(1-3):195-202

Institute of Experimental Medicine, Hungarian Academy of Sciences, Szigony u. 43, H-1083 Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejphar.2004.07.057DOI Listing
September 2004

Raloxifene lowers ischaemia susceptibility by increasing nitric oxide generation in the heart of ovariectomized rats in vivo.

Eur J Pharmacol 2004 Jul;495(2-3):179-84

Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1083 Budapest, Szigony u. 43, Hungary.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S001429990400558
Publisher Site
http://dx.doi.org/10.1016/j.ejphar.2004.05.039DOI Listing
July 2004

Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate.

J Bone Miner Res 2004 May 19;19(5):745-51. Epub 2004 Jan 19.

Division of Research, Kaiser Permanente Medical Care Program, Oakland, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1359/JBMR.040117DOI Listing
May 2004

Associations between baseline risk factors and vertebral fracture risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) Study.

J Bone Miner Res 2004 May 16;19(5):764-72. Epub 2004 Feb 16.

Department of Orthopaedics, Malmö General Hospital, Malmö, Sweden.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1359/jbmr.040211
Publisher Site
http://dx.doi.org/10.1359/JBMR.040211DOI Listing
May 2004

Raloxifene prevents the growth of uterine leiomyomas in premenopausal women.

Fertil Steril 2004 Jan;81(1):132-6

Department of Obstetrics and Gynecology, University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.fertnstert.2003.06.009DOI Listing
January 2004

Role of flanking sequences and phosphorylation in the recognition of the simian-virus-40 large T-antigen nuclear localization sequences by importin-alpha.

Biochem J 2003 Oct;375(Pt 2):339-49

Structural Biology Laboratory, St. Vincent's Institute of Medical Research, 41 Victoria Parade, Fitzroy, Victoria 3065, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1042/BJ20030510DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1223685PMC
October 2003

Mood effect of raloxifene in postmenopausal women.

Maturitas 2002 May;42(1):71-5

Mental Health Research Center, Russian Academy of Medical Sciences, Kashirskoye Shosse 34, Moscow, Russia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0378-5122(01)00303-6DOI Listing
May 2002